Acute Carotid Sinus Endovascular Stimulation II Study

All study objectives are being assessed during the intraoperative baroreceptor stimulation. No subsequent testing will be performed. The follow-up visit is only intended to assess for adverse events.

Inclusion criteria

• Subject is at least 18 years old
• Subject is hypertensive (defined as at least one in-office Systolic BP measurement ≥140 mm Hg or Diastolic BP ≥90 mm Hg within three months prior to enrollment
• Subject is undergoing a cardiac catheterization involving right heart catheterization and/or EP procedures.
• Subject (or subject's legally authorized representative) is able and wiling to give informed consent

Exclusion criteria

• Subject has an ejection fraction (EF) less than 35% (by most recent echocardiography in the past 6 months) and there has been no change in clinical status relative to EF
• Subject is a woman who is pregnant, nursing, or of child bearing potential and is not on a reliable form of birth control
• Subject is enrolled or is planning to participate in a concurrent drug and/or device study during the course of this clinical trial. Co-enrollment in concurrent trials is only allowed with documented pre-approval from the Medtronic study manager, documenting that there is not a concern that co-enrollment could confound the results of this trial.
• Subject is unable or unwilling to participate with study procedures